BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 35406451)

  • 1. Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.
    Peña-Romero AC; Orenes-Piñero E
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment.
    Malavasi E; Adamo M; Zamprogno E; Vella V; Giamas G; Gagliano T
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acidic tumour microenvironment: Manipulating the immune response to elicit escape.
    Worsley CM; Veale RB; Mayne ES
    Hum Immunol; 2022 May; 83(5):399-408. PubMed ID: 35216847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocytes against solid malignancies: winning ways to defeat tumours.
    Caruana I; Simula L; Locatelli F; Campello S
    Cell Stress; 2018 Jul; 2(8):200-212. PubMed ID: 31225487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multifaceted Role of Macrophages in Oncolytic Virotherapy.
    Hofman L; Lawler SE; Lamfers MLM
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment.
    Dang N; Waer M; Sprangers B; Lin Y
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31683642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Autophagy in Tumor Immunology-Complex Mechanisms That May Be Explored Therapeutically.
    de Souza ASC; Gonçalves LB; Lepique AP; de Araujo-Souza PS
    Front Oncol; 2020; 10():603661. PubMed ID: 33335860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Exercise on the Tumour Microenvironment.
    Buss LA; Dachs GU
    Adv Exp Med Biol; 2020; 1225():31-51. PubMed ID: 32030646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Molecular Imaging of the Tumour Microenvironment.
    Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
    Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy.
    Salemme V; Centonze G; Cavallo F; Defilippi P; Conti L
    Front Oncol; 2021; 11():610303. PubMed ID: 33777750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression.
    Armitage JD; Newnes HV; McDonnell A; Bosco A; Waithman J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles in the Tumour Microenvironment: Eclectic Supervisors.
    Cavallari C; Camussi G; Brizzi MF
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immune escape in different digestive tumours.
    Du XZ; Wen B; Liu L; Wei YT; Zhao K
    World J Clin Cases; 2021 Dec; 9(34):10438-10450. PubMed ID: 35004976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.